Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Seoul names 19 'medical-friendly' hotels for foreign patients

Seoul has designated 19 hotels and accommodations as “medical-friendly” lodgings tailored for international patients and their families, part of an effort to capture a growing global market traveling to Korea for health care, the city government said Monday. According to the Korea Health Industry Development Institute, about 1.76 million foreign patients were treated at medical institutions in…

Seoul names 19 'medical-friendly' hotels for foreign patients

Seoul has identified 19 hotels and accommodations as "medical-friendly" lodgings specifically designed for international patients and their families, according to the city government. This initiative aims to tap into the expanding global market of individuals traveling to Korea for healthcare, with the city government announcing the selection on Monday.

In 2025, Seoul treated a record high of 1.76 million foreign patients, a three-and-a-half times increase from the 470,000 treated in 2023. The Seoul Metropolitan Government and the Seoul Tourism Organization chose the 19 facilities from among 40 applicants in the program's inaugural year. The selection process involved document reviews, on-site inspections, and expert evaluations.

Unlike typical tourists, foreign patients frequently require extended stays that align with their treatment schedules, rooms for family members or caregivers, and spaces for recovery post-surgery or other procedures. Some patients may also struggle with mobility following their treatment. The facilities were assessed based on their accessibility and willingness to accommodate these specific needs.

Written by urgent.news from The Korea Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Also reported by 1 other outlet

Read the original at koreatimes.co.kr →

More in Health & Medicine

GC Biopharma Signs VaxThera Vaccine Deal

Contract Worth About KRW 59.2 Billion Backed by RIGHT Foundation Funding GC Biopharma said on Nov. 2 that it signed a contract with VaxThera, a Colombian vaccine company, for technical support for…

  • GC Biopharma signs KRW 59.2 billion deal with VaxThera for influenza vaccine production.
  • GC Biopharma supplies bulk drug substance and process technology support.
  • VaxThera manages filling, packaging, quality control, and local distribution.

More from Monday 2 November →